AbCellera Biologics Inc. (ABCL)
|Gross Profit (TTM)||$311.11M|
|Year Range||$3.87 - $12.72|
Share Price Chart
The chart shows the growth of an initial investment of $10,000 in AbCellera Biologics Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
AbCellera Biologics Inc. had a return of -52.32% year-to-date (YTD) and -63.35% in the last 12 months.
|5 years (annualized)||N/A||10.75%|
|10 years (annualized)||N/A||9.87%|
Monthly Returns Heatmap
This table presents a comparison of risk-adjusted performance metrics for AbCellera Biologics Inc. (ABCL) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
The Drawdowns chart displays portfolio losses from any high point along the way.
The table below displays the maximum drawdowns of the AbCellera Biologics Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the AbCellera Biologics Inc. was 93.36%, occurring on Oct 27, 2023. The portfolio has not yet recovered.
|-93.36%||Dec 14, 2020||723||Oct 27, 2023||—||—||—|
The current AbCellera Biologics Inc. volatility is 17.74%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.